Chronic myeloid leukemia presenting in lymphoblastic crisis, a differential diagnosis with Philadelphia-positive B-lymphoblastic leukemia.
Zhining ChenShimin HuSa A WangMarina KonoplevaZhenya TangJie XuShaoying LiGokce TorunerBeenu ThakralL Jeffrey MedeirosGuillin TangPublished in: Leukemia & lymphoma (2020)
Rare patients with chronic myeloid leukemia (CML) can present initially in lymphoblastic crisis (LBC) mimicking Ph + B-lymphoblastic leukemia (B-ALL). We retrospectively reviewed 275 adults who diagnosed initially as Ph + B-ALL and identified 28 patients with at least one of three features supporting the diagnosis of CML-LBC: 1) a large discrepancy between the blast count and Ph + clone; 2) Ph + clone persistent when B-ALL in remission; 3) BCR/ABL1 fusion detected in segmented cells. BCR-ABL1 fusions were p210 in 25 patients and p190 in 3 patients. In comparison to patients with Ph + B-ALL, patients with CML-LBC were older; had higher leukocyte and absolute neutrophil counts; higher immature myeloid cells in peripheral blood; lower blast counts; and inferior outcomes. In addition, we prospectively analyzed 26 patients with Ph + B-lymphoblastic leukemia and identified 8 patients with features more consistent with CML-LBC. These findings highlight the importance of distinguishing CML-LBC from de novo Ph + B-ALL.
Keyphrases
- chronic myeloid leukemia
- peripheral blood
- end stage renal disease
- acute myeloid leukemia
- bone marrow
- newly diagnosed
- induced apoptosis
- ejection fraction
- public health
- cell cycle arrest
- peritoneal dialysis
- prognostic factors
- type diabetes
- dendritic cells
- signaling pathway
- acute lymphoblastic leukemia
- tyrosine kinase
- physical activity
- cell proliferation
- systemic lupus erythematosus
- skeletal muscle
- endoplasmic reticulum stress
- metabolic syndrome
- insulin resistance
- clinical evaluation